Medtronic (NYSE: MDT) announced that on May 8, 2015, it began notifying hospitals and distributors worldwide that affected lots of its Covidien Shiley(TM) tracheostomy tubes were formed with a wider-angle bend than standard models manufactured after November 29, 2012. The company initiated the field action following a small number of customer … [Read more...]
Search Results for: Medtronic
Medtronic to Halt Production and Distribution of Certain Drug Pumps
In compliance with a consent decree filed by the U.S. Food and Drug Administration (FDA), Medtronic has agreed to stop production and distribution of Synchromed II drug pumps, except in special cases. The problem with the defective pumps is that they can deliver too much or too little medication, or patients may experience delayed therapy. The … [Read more...]
Medtronic Recalls 60,000 Paradigm Quick-Set Infusion Sets
Medtronic has issued a recall of specific lots of infusion sets that are for use with MiniMed Paradigm insulin pumps. These infusion sets may not work properly, resulting in a delivery of too little or too much insulin, which could result in injury or death. The infusion set is the thin plastic tube that delivers insulin from the pump to the … [Read more...]
Medtronic Voluntarily Recalls Specific Lots of Paradigm® Quick-Set® Infusion Sets In The United States
UPDATED URL > Click Here for information on the Medtronic Paradigm Quick Set Infusion Set Recall … [Read more...]
FDA Classifies Medtronic Voluntary February Recall for BioGlide Ventricular Snap Shunt Catheters (Models 27782, 27708 and 27802) as Class I
CONTACT: JEFF WARREN INVESTOR RELATIONS 763-505-2696 CHUCK GROTHAUS PUBLIC RELATIONS 763-505-2614 MEDTRONIC, INC. (NYSE: MDT) ANNOUNCED THAT THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) CLASSIFIED AS CLASS I ITS VOLUNTARY RECALL ACTION INITIATED ON FEBRUARY 11, 2009 OF ITS BIOGLIDE VENTRICULAR SNAP SHUNT CATHETER (CAT. #S 27782, 27708 AND 27802) … [Read more...]
Recent Comments